Disagreeing on how to treat CFS patients.
Leyton
E
E
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000529:Complementary Therapies; D004338:Drug Combinations; D015673:Fatigue Syndrome, Chronic / Q000628:therapy*; D005228:Fatty Acids, Essential / Q000627:therapeutic use*; D005395:Fish Oils / Q000627:therapeutic use*; D006801:Humans; D008041:Linoleic Acids; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D031665:Oenothera biennis; D010938:Plant Oils; D017965:gamma-Linolenic Acid
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D005228:Fatty Acids, Essential; D005395:Fish Oils; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D008278:Magnesium Sulfate; D017965:gamma-Linolenic Acid